“Simvastatin treatment reduces the cholesterol content of membrane/lipid rafts, implicating the N -methyl-D-aspartate receptor in anxiety: a literature review”, Braz. J. Pharm. Sci., vol. 53, no. 1, p. e16102-, Jan. 2017, doi: 10.1590/s2175-97902017000116102.